Developmental dysplasia of the hip (DDH) is a common deformity of the hip joint characterized by abnormal acetabular shape and subluxation of femoral head, which endangers severely the skeletal development of children. 1 It affects approximately 1 to 5 per 1,000 newborns in China 2 and 1 in 1,000 in the United States, 3 in which female are more frequently involved with a sex-ratio of 4-10:1. 4 This malformation, although most cases recover spontaneously in early life, is a common cause of childhood disability and adult hip osteoarthritis. 5 Therefore, it is crucial to offer diagnosis and therapy at early age of affected infants to avoid or reduce putative damage this disorder may cause.
The etiology of DDH is complex, comprising environmental and genetic factors. Breech presentation, swaddling position, primiparity, oligohydramnios, and high birthweight have been identified as environmental risk factors. 6, 7 Besides, genetic association has been established through epidemiologic studies 8, 9 concluding that monozygotic twins showed higher concordance than dizygotic twins and that first-degree relatives of DDH patients were more likely to be affected. Several genes, such as HOXD9, 10 DKK1, 11 GDF5, 12 and so on, were revealed to be susceptibility genes of DDH through candidate association studies in population.
Through genome-wide linkage analysis on a 72-member, 4-generation DDH-affected family in USA, Feldman et al. 13 identified a candidate region with a LOD score of 3.31 which included CX3CR1 gene. Subsequent whole-exome sequencing (WES) revealed that a variant, rs3732378 of CX3CR1, was shared by four severely affected members. This variant, causing a threonine to methionine substitution in the transmembrane domain of CX3CR1 protein and predicted to be deleterious in silico, was confirmed in all affected individuals by later Sanger sequencing, implying that it was a disease-causing mutation for DDH. Although this variant was co-segregated with familial DDH, the lack of evidence from population has weakened the conclusion that CX3CR1 was a putative gene involved in the pathogenesis of DDH. Therefore, validation in unrelated patients was urged to confirm the role of CX3CR1 in the development of DDH.
Given this reason, we designed a case-control association study to explore the correlation between CX3CR1 and sporadic DDH. Two variants in the same transmembrane domain, rs3732378 and rs3732379, were selected for our study.
METHODS Participants
This is a retrospective case-control study with Level III of evidence. A total of 689 Chinese Han unrelated DDH patients were recruited from the Department of Pediatric Orthopedics, Shengjing Hospital of China Medical University. DDH was diagnosed by two experienced experts of pediatric orthopedics according to medical history and results of physical examination and pelvic radiograph. Patients with syndromic hip dislocation were excluded. The patient group comprised 127 males and 562 females.
The control group contained 689 DDH-free individuals that were enrolled from the same department. All the controls were diagnosed as hip synovitis and any patient with congenital malformations, hereditary diseases, hip dislocation, or family history of DDH was ruled out. The control group is consisted of 389 males and 300 females.
This research was approved by the Medical Ethic Committee of Shengjing Hospital of China Medical University. Informed written consents were obtained from all the patients' parents. After agreement, 1 ml peripheral venous blood was collected, treated with EDTA anticoagulant, and stored at À80˚C.
Genotyping
Genomic DNA was extracted from peripheral blood using QIAamp DNA Blood mini kit (Qiagen, Duesseldorf, German) according to the manufacture protocols. Two SNPs, rs37232378 G>A and rs37232379 C>T, were genotyped with TagMan real-time PCR method using the 7500 real-time PCR instrument (Applied Biosystems, Foster City, CA). The reaction was performed in 20 ml mixtures comprising 0.5 ml 40Â TaqMan genotyping assay mix, 4 ml DNA template, 10 ml TaqMan genotyping master mix, and 5.5 ml ultrapure water. The PCR conditions were set as follows: predenaturation at 95˚C for 10 min, denaturation at 95˚C for 15 s, annealing at 60˚C for 1 min, and extension at 60˚C for 10 min for a total of 40 cycles. Statistics SPSS 11.5 software (SPSS, Chicago, IL) was applied to perform the statistical analyses. Hardy-Weinberg Equilibrium (HWE) in control group was assessed by chi-squared test. We applied Student's t-test to compare the age distribution and chi-squared test for gender distribution. The frequency distributions of alleles and genotypes in both groups were compared using chi-squared test or Fisher exact test when necessary. Odds ratio (OR) and 95% confidence interval (95%CI) were calculated to represent the association between SNPs and DDH, which were adjusted for gender after logistic multi-factor regression analysis later. Haplotype analysis was performed using Haploview 4.2 software. p-value <0.025 was considered statistically significant.
RESULTS

Distribution of Genotypes and Alleles
The genotyping results were shown in Table 1 . The age of patients and controls was 2.4 (AE1.04) and 3.12 (AE2.91) years on average (AESD), respectively and they were significantly different (p < 0.001), the similar with gender distribution (p < 0.001). Two SNPs of CX3CR1, rs3732378, and rs3732379, were genotyped and both were in Hardy-Weinberg Equilibrium (p ¼ 0.359 and 0.572, respectively) in control group. For rs3732378, significant differences were observed in both genotype and allele distributions between DDH and control groups (p ¼ 0.003 for genotype distribution and 0.001 for allele distribution). After adjustment for gender, this polymorphism still showed significant association with DDH, of which the A allele carriers had a 2.25-fold risk of developing DDH compared to G allele carriers (adjusted OR ¼ 2.25, 95%CI 1.42-3.56).
Similar results were obtained with respect to rs3732379. The genotypes were unequally distributed between DDH and control groups, revealing that this alteration was associated with this deformity. Furthermore, carrying T allele may confer a 1.84-fold risk to hip dislocation after adjustment (adjusted OR ¼ 1.84, 95%CI 1.19-2.84).
Haplotype Analysis
Haplotype analyses were carried out to investigate the association of CX3CR1 polymorphisms and DDH ( Table 2 ). The haplotype GC was more frequent in controls (OR ¼ 0.45, 95%CI 0.33-0.62, p < 0.001), whereas more patients carried the haplotypes GT (OR ¼ 2.22, 95%CI 1.40-3.59, p ¼ 0.001) or AC (OR ¼ 2.82, 95%CI 1.68-4.74, p < 0.001) than controls.
DISCUSSION
CX3CR1 is located in chromosome 3p21.3 and consisted of two exons. It encodes a receptor of chemokine CX3CL1, which includes a G-protein coupled transmenbrane domain. This receptor is expressed in monocytes, T lymphocytes, and natural killer cells. Thus, those cells show a high affinity to other cells expressing membrane-bound CX3CL1. CX3CR1 mediates the adhesion and aggregation of leukocytes and is involved in the migration of leukocytes to inflammatory tissues, thus playing an important role in inflammation development. 14 Apart from this, in human mesenchymal stem cells (MSCs) induced to differentiate towards chondrocytes, CX3CR1 is highly expressed in MSCs and becomes completely inhibited during chondrocyte development. 15 This modulation of expression may indicate a putative role of CX3CR1 in the differentiation or migration of MSCs and the cartilage development of the acetabulum.
Recently, CX3CR1 was proposed as a candidate gene of DDH based on analyses on a large DDHaffected family. Genome-wide linkage analysis mapped the candidate genes to a 1.75 Mb region on chromosome 3. Through WES on four severely affected members, only one predicted-deleterious missense variant was identified to be shared. This variant, rs3732378, was located in the transmembrane domain of CX3CR1, suggesting that CX3CR1 was the putative pathogenic gene of this familial disorder. Our study provided further evidence from sporadic cases. After genotyping two polymorphisms in 689 DDH patients and 689 ethnicity-matched controls, significantly differences were observed in genotype and allele distributions between two groups, indicating that CX3CR1 was correlated with the risk of sporadic DDH. Supporting evidence may also come from analysis of mouse model finding size discrepancy of unilateral acetabulum between CX3CR1 knockout and wild-type mice. 16 Combining research results of pedigree, population, and mouse model, we could come to a conclusion that CX3CR1 tends to play an important and functional role in the pathogenesis of DDH.
As for rs3732378, a variant considered to be pathogenic previously, our study proved it to be a susceptibility locus of DDH. The frequency of altered allele was higher in unrelated patients than that in controls (4.79% vs. 2.47%), conferring a 2.25-fold risk to the carriers. Similarly, the minor allele of another polymorphism, rs3732379, was more frequent in cases than in controls (4.93% vs. 2.90%). These two polymorphisms are both missense that result in amino acid substitutions (T280M for rs3732378 and V249I for rs3732379) in the transmembrane domain of CX3CR1 protein. As a result, the polarity of amino acids changes from polar to non-polar, which may be deleterious to the structure and function of encoded protein. Given the high allele frequencies in population and results of our association study, these two polymorphisms tend to be risk factors instead of disease-causing variants. With regard to the co-segregation of rs3732378 with DDH in previous study, we hypothesized there were other variants in introns underlying this familial disorder. These intron variants were in disequilibrium with rs3732378 but could not be detected by WES. Consequently, rs3732378 turned out to be co-segregated with familial DDH.
In conclusion, our study demonstrated that CX3CR1 was a candidate gene for the etiology of DDH and identified rs3732378 and rs3732379 as risk factors of DDH.
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